SEC Form SC 13D filed by EG Acquisition Corp.

This Statement on Schedule 13D (this “Schedule 13D”) is being filed with the U.S. Securities and Exchange Commission (“SEC”) with respect to the Class A common stock, $0.0001 par value per share (the “Common Stock”) of flyExclusive, Inc., the successor entity of EG Acquisition Corp. (the “Issuer”). Third Point LLC, a Delaware limited liability company (the “Management Company”), and Daniel S. Loeb (“Mr. Loeb” and, together with the Management Company, the “Reporting Persons”) have previously filed a Schedule 13G (the “Schedule 13G”) with the SEC, related to their investment in the Issuer, on June 9, 2023.

Item 1. Security and Issuer.

This Schedule 13D relates to the shares of Common Stock, of the Issuer. The Issuer’s principal executive offices are located at 375 Park Avenue, 24th Floor, New York, NY 10152.

Item 2. Identity and Background.

(a) This Schedule 13D is being filed by the Reporting Persons.

(b) The principal business address of the Reporting Persons is 55 Hudson Yards New York, New York 10001.

(c) The principal business of the Management Company is to serve as investment manager or adviser to a variety of hedge funds and managed accounts (such funds and accounts, collectively, the “Funds”), and to control the investing and trading in securities of the Funds. The principal occupation of Mr. Loeb is serving as Chief Executive Officer of the Management Company.

(d) (e) During the last five years, none of the Reporting Persons (i) has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

(f) Mr. Loeb is a citizen of the United States of America.

Item 3. Source and Amount of Funds or Other Consideration

The Reporting Persons and Funds may effect purchases of shares of Common Stock through margin accounts maintained for them with brokers, which extend margin credit as and when required to open or carry positions in their margin accounts, subject to applicable federal margin regulations, stock exchange rules and such firms’ credit policies. Positions in shares of Common Stock may be held in margin accounts and may be pledged as collateral security for the repayment of debit balances in such accounts. Such margin accounts may from time to time have debit balances. In addition, since other securities may be held in such margin accounts, it may not be possible to determine the amounts, if any, of margin used to purchase shares of Common Stock.

Item 4. Purpose of Transaction.

The Reporting Persons originally acquired the securities reported herein for investment purposes.

Except as set forth herein, the Reporting Persons have no present plans or proposals that relate to or would result in any of the matters set forth in subparagraphs (a) – (j) of Item 4 of Schedule 13D.

Item 5. Interest in Securities of the Issuer.

(a) On the date of this Schedule 13D, the Reporting Persons beneficially own an aggregate of 1,389,499 shares of Common Stock held by the Funds, including (including 367,499 shares of Class A Common Stock issuable upon the exercise of warrants of the Issuer) (such shares, the “Shares”). The Shares represent approximately 7.90% of the Issuer’s Common Stock outstanding. Calculations of the percentage of Common Stock beneficially owned assumes 17,592,475 (including 367,499 shares of Class A Common Stock issuable upon the exercise of warrants of the Issuer) shares of Common Stock outstanding as of December 31, 2023, as further described in the Issuer’s Registration Statement on Form S-1, as filed with the SEC on January 19, 2024.

(b) Each of the Reporting Persons shares voting and dispositive power over the Shares held directly by the Funds.

(c) Except as set forth in this Schedule 13D, the Reporting Persons have not effected any transactions in the shares of Common Stock during the past sixty days, inclusive of any transactions effected through 4:30 p.m., New York City time, on February 13, 2024. The information contained in Item 6 is incorporated herein by reference.

(d) Other than the Funds that directly hold the Shares, and except as set forth in this Item 5, no other person is known to have the right to receive, or the power to direct the receipt of, dividends from or proceeds from the sale, of the Shares.

(e) Not applicable.

Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

The information contained in Items 3, 4 and 5 is incorporated by reference herein, as applicable.

Among other things, certain shares of Class A Common Stock held by the New Holders, will be entitled to registration rights pursuant to A&R Registration Rights Agreement, requiring the Issuer to register such securities for resale. Pursuant to the A&R Registration Rights Agreement, the New Holders holding at least a majority-in-interest of the then-outstanding number of registrable securities held by the New Holders will be entitled to, among other things, make a written demand for registration under the Securities Act of all or part of their shares of Class A Common Stock (a “Demand Registration”). Under no circumstances shall the Issuer be obligated to effect more than an aggregate of five registrations pursuant to a Demand Registration by the New Holders, with respect to any or all registrable securities held by such holders. In addition, the New Holders will be entitled to “piggy-back” registration rights to certain registration statements filed following the business combination. The Issuer will bear all of the expenses incurred in connection with the filing of any such registration statements.

Item 7. Material to Be Filed as Exhibits.

SIGNATURES

After reasonable inquiry and to the best of its or his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: February 13, 2024

INDEX TO EXHIBITS